In recent years, small molecule antagonists, antisense oligonucleotides, and monoclonal antibodies targeting GCGR have been developed and demonstrated efficacy in improving glycemic control in both rodent models of diabetes and human patients with diabetes 8,9,10,11,12,13
These antibodies also enhance the efficacy of antifungals such as amphotericin B, fluconazole, and flucytosine, demonstrating synergistic effects in animal models and in vitro assays (Gordon and Lapa, 1964
The peptide can be administered subcutaneously, with some researchers using it in the same protocol alongside BPC-157 and TB-500
These are the DNA nitrogen bases, the DNA nitrogen base pairs, certain free radicals which are responsible for oxidative stress and GSH which is apparently important as it is involved in the genotoxic activity of copper compounds [52-58]
Its also beneficial for stress relief, recovery after workouts, and overall hydration balance
These products fall outside conventional NHS prescribing practices